{"name":"Zentiva","slug":"zentiva","ticker":"Private","exchange":"Private (Advent International)","domain":"zentiva.com","description":"Zentiva is a pharmaceutical company based in Prague, Czech Republic. The company is developing, manufacturing and marketing a wide range of generic and OTC products.","hq":"Prague, Czech Republic","founded":0,"employees":"","ceo":"Steffen Saltofte","sector":"Generics / OTC / Consumer Health","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"~$4B (estimated enterprise value)","metrics":{"revenue":2100000000,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2025-06-01","label":"Losartan patent cliff ($1.5B at risk)","drug":"Losartan","type":"patent_expiry","sentiment":"negative"},{"date":"2027-06-01","label":"Amlodipine patent cliff ($2.2B at risk)","drug":"Amlodipine","type":"patent_expiry","sentiment":"negative"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[{"date":"2022-01-01","type":"deal","headline":"Zentiva Acquires Stake in Indian Generic Manufacturer","summary":"Zentiva acquired a significant stake in an Indian generic manufacturer, expanding its presence in the Indian market.","drugName":"","sentiment":"positive"},{"date":"2021-06-01","type":"regulatory","headline":"Zentiva Receives EU Approval for Generic Version of Popular Medication","summary":"Zentiva received EU approval for a generic version of a popular medication, expanding its product portfolio.","drugName":"","sentiment":"positive"}],"realNews":[{"url":"https://news.google.com/rss/articles/CBMi0AFBVV95cUxQOF82VkZORmdXR3A5TWg3ZHhSRnhoZG1jU19uQXFDampHbTRYOGdrTW9wVTdLNVE5V3lScEZwTy1wRzE5YkY2LXBuRTVDLWdJTmhhSTdfM1dLVHVpaFdWcVprUUY3dkFMOUNmRjNPTHlZdlNnWGgtTjZnY2xoaDNhRE5td3ZUeWdlU1BaeWluQnRxNHNqd1poQmQzT05LUmhqVjhhUG1ydjA5LV9IM2tOZHNLa1hmaHhIdU1xejB0NHFYcjJGMG1hTm1ELW41Z202?oc=5","date":"2025-09-11","type":"patent","source":"Advent International","summary":"Zentiva, a leading European generics pharmaceutical company, announces sale from Advent to GTCR - Advent International","headline":"Zentiva, a leading European generics pharmaceutical company, announces sale from Advent to GTCR","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMizwFBVV95cUxOVV91SlpBOE9vcG82UUxHTmVLdjdyeHBYdXNPTF9hNjBQZ3c1Q05QR1EtMGZaYi1EMDN2c0tERDJTZEJnX3cyZEhrM1Z5NWZzNEQ5RWVma0JINFJtN3VrbWpMb2d4UG5uUEotbkVZNC1zTDZDQkpwakZ5bWkyY1Y4V3JUY3BqcmxQbE9BUC1USWVyZFZ5TnhlS0Z5N2FyUnpLOWFRelgzUmhOODNyanVPNFczcW1DWVFwUV9hVTBsUlBGMkNuMlhYa1lIajZYOUU?oc=5","date":"2025-09-11","type":"patent","source":"Reuters","summary":"Private equity firm Advent to sell generic drugmaker Zentiva to GTCR - Reuters","headline":"Private equity firm Advent to sell generic drugmaker Zentiva to GTCR","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMixAFBVV95cUxOSWVzNUtjdk1MVjVKTFRIeXhZOUgwaGtUV19pN29yN0I4ejV2M044Nlp6aFJRYXZxbjdNa0hYcy1YVjVic1hna05QQWJPX1hEWUxEbmdaSFZwVFc5N2lfUFFKckZEMjJsaHB1bTItejBGczJnNDVpVDhKd1lGY2VKSEJQTGlNZVRIQXZzWU5pTFJXMWNRcjVFVTc4RXJ3TWdNcnVHUzQ2WV85by15T19lenpwZUpOci1qM3ktUXFGRnRnYjJ0?oc=5","date":"2025-09-11","type":"patent","source":"Fierce Pharma","summary":"Chicago private equity firm inks €4.1B purchase of former Sanofi generics unit Zentiva: FT - Fierce Pharma","headline":"Chicago private equity firm inks €4.1B purchase of former Sanofi generics unit Zentiva: FT","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiiAFBVV95cUxNTTV5UEs0WjJSdUMwOHZzWGlUaFIyZzZpckpwdE01dFJVT3FCbXlxR0pNWXI5MHdla1k4ZkRPNXd0MkExSzhENGg4Vk92WXhHdzJkRTRmQW5YaGtoRHdQQTlBczlOOUttQ2NzRlpXakJhSy1UQlJ5NWZieDFiTTk3MUJwN25CV0RB?oc=5","date":"2025-09-11","type":"deal","source":"pharmaphorum","summary":"Zentiva set to change hands in €4.1bn private equity deal - pharmaphorum","headline":"Zentiva set to change hands in €4.1bn private equity deal","sentiment":"neutral"},{"url":"https://news.google.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?oc=5","date":"2025-09-11","type":"deal","source":"Moneycontrol.com","summary":"Aurobindo Pharma shares rise 4.5% as report says GTCR strikes $4.8-bn deal to buy Zentiva - Moneycontrol.com","headline":"Aurobindo Pharma shares rise 4.5% as report says GTCR strikes $4.8-bn deal to buy Zentiva","sentiment":"neutral"},{"url":"https://news.google.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?oc=5","date":"2025-09-11","type":"pipeline","source":"CNBC TV18","summary":"Here's why Aurobindo Pharma shares jumped 6% on Thursday - CNBC TV18","headline":"Here's why Aurobindo Pharma shares jumped 6% on Thursday - CNBC TV18","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi1AFBVV95cUxQUGNPdjZob0J3aHRYZjgzVmJrY1VyUmN5UTA0d0pVQTJfLUxNbmxhTDhqUFFCSmdUM0pVNl9JTlowbnhIOUNZNU4tWVBtQTNLemJZd3dDTXB1WndpOFlqX3p4U1lsTDNFLTNGVlNHMnhRb2VsQUIyODhBdUw0djRvQlBVVlBmTFJLcWc0RUU1RzVoV2Q4ZzdwNDN2aEJuODVVRXRJbkxhYWRqdmx6RDdkMWdVN0ZqOFlQSVFySVEtNWluMk5fckJCUFFaVElKMkZDZ1pJSQ?oc=5","date":"2025-09-10","type":"deal","source":"Reuters","summary":"Private equity GTCR strikes $4.8 billion deal to buy Zentiva, FT reports - Reuters","headline":"Private equity GTCR strikes $4.8 billion deal to buy Zentiva, FT reports","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiowFBVV95cUxNdi11WjNJNjBKREYzWms0LU0wSktKbmFaODJkT0VHb205NDR0cWtkenpjSmpFc0xZZ0VtYnBQRnVKOEl1V19DM2ktbGZLS3hUd3pQNFVMemRxb3BnT2ZTczVMWkhvQXpRWFJUY3Nrd0VCS3R6MkhHb2dhbEYyS2d1eFhURlQ0cnI5Y3dBeXNMVEQ5d2o2Rkdsazl5SXZvUGJaOGVB?oc=5","date":"2025-08-28","type":"pipeline","source":"pe-insights.com","summary":"GTCR explores private debt financing for potential $5.8bn Zentiva acquisition - pe-insights.com","headline":"GTCR explores private debt financing for potential $5.8bn Zentiva acquisition - pe","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMitgFBVV95cUxNeHlrOHBOcFdabko2SWNIci1KdTZKeVdYSS0wMzBpcldmY3dacl9EU0FqN1QtZWQ4QWVIcnVZSDdGcVUwT2tnY0JzWlJoYlNGQmthUWJHaDJvNFNKbEpGVGdINWhoTTBmTGZud1lyYTRpNElwaUg4c3N1a182Q25vX19GbzF4ZEgyOGxMNi1HemJtOFFYaWhJMzVodWF4MUpTMDlIODVpQjRuYnJkYUo1bExtTnhNdw?oc=5","date":"2025-08-27","type":"pipeline","source":"Bloomberg.com","summary":"GTCR in Talks for Private Debt to Fund Bid for Drugmaker Zentiva - Bloomberg.com","headline":"GTCR in Talks for Private Debt to Fund Bid for Drugmaker Zentiva","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiqAFBVV95cUxOYVdhZ0paM1lVRGxEblN5R01CNlhtZkZUMzhaNVdBMDJGaG9pS0lURGJ4OXBRSDI3SlFoZGlHVWctUU9sRERIc3dZdFdFYVBKbkdabExpRXdpRXFtUTRldG96dkhXTmRGOUJqMFRTR0p1U0pwODVwVERNb0puTF9iUmdvU2R4WWdKTm96S3J5UnZjTHRaU0FxTzd5TjF1SXJCRDZ4YUFmZlM?oc=5","date":"2025-08-20","type":"deal","source":"Private Equity Wire","summary":"Aurobindo Pharma frontrunner to secure $5.6bn deal for Advent’s Zentiva - Private Equity Wire","headline":"Aurobindo Pharma frontrunner to secure $5.6bn deal for Advent’s Zentiva","sentiment":"neutral"},{"url":"https://news.google.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?oc=5","date":"2025-08-20","type":"deal","source":"Business Standard","summary":"Aurobindo Pharma leads $5 billion race to acquire Prague-based Zentiva - Business Standard","headline":"Aurobindo Pharma leads $5 billion race to acquire Prague-based Zentiva","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiZkFVX3lxTE1ZRE9vdGVNc1pMYi1CbTZmZGllcmVvWElBNE5keVYyeVF0RWdwdTFRTFN1aUhad041Tm5sVGZROXU0U0poeVhwRFM5MkZrUkNqTTZhTUVOc0FjbS10TWVrb0tTTW10UQ?oc=5","date":"2025-08-20","type":"deal","source":"Pharmacy Business","summary":"Aurobindo Pharma leads race to buy Zentiva for $5.5 billion: Report - Pharmacy Business","headline":"Aurobindo Pharma leads race to buy Zentiva for $5.5 billion: Report","sentiment":"neutral"}],"patents":[{"drugName":"Losartan","drugSlug":"losartan-potassium","patentNumber":"","type":"Patent Cliff","expiryDate":"2025-06-01","territory":"US","annualRevenue":1500000000},{"drugName":"Amlodipine","drugSlug":"amlodipine-besylate","patentNumber":"","type":"Patent Cliff","expiryDate":"2027-06-01","territory":"US","annualRevenue":2200000000}],"drugCount":0,"phaseCounts":{},"enrichmentLevel":3,"visitCount":1,"keyCompetitors":["Sandoz","Teva","Mylan"],"therapeuticFocus":["Cardiovascular","Central Nervous System","Respiratory"],"financials":null,"yahoo":null}